Nothing Special   »   [go: up one dir, main page]

Fisher et al., 1998 - Google Patents

Properties of poly (ethylene glycol)-conjugated red blood cells

Fisher et al., 1998

Document ID
14290221231997950139
Author
Fisher T
Armstrong J
Meiselman H
Leger R
Arndt P
Garratty G
Publication year
Publication venue
Blood Substitutes, Present and Future Perspectives

External Links

Snippet

Poly (ethylene glycol)(PEG) is an amphiphilic linear polymer, which is non-immunogenic, non-toxic and chemically inert in biological systems [1, 2]. Twenty years ago, Abuchowski et al.[3, 4] developed a technique to modify proteins by the covalent attachment of PEG, using …
Continue reading at books.google.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48169Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
    • A61K47/48192Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas, polyurethanes
    • A61K47/48215Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas, polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer, dendrimer, e.g. PEG, PPG, PEO, polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026Blood substitute; Oxygen transporting formulations; Plasma extender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells

Similar Documents

Publication Publication Date Title
US6129912A (en) Polyethylene glycol-protein compositions which reduce the antigenic display of red blood cells
US10441606B2 (en) Polymers for reversing heparin-based anticoagulation
Bradley et al. Biophysical consequences of linker chemistry and polymer size on stealth erythrocytes: size does matter
AU637996B2 (en) Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids
JP2647556B2 (en) Polyoxypropylene / polyoxyethylene copolymers with improved biological activity
Vert et al. Poly (ethylene glycol): protein-repulsive or albumin-compatible?
US20070212300A1 (en) Delivery of compounds with rehydrated blood cells
US6312685B1 (en) Red blood cells covalently bound with two different polyethylene glycol derivatives
Armstrong et al. Modulation of red blood cell aggregation and blood viscosity by the covalent attachment of Pluronic copolymers
EP0901521A1 (en) Antigenic modulation of cells
Wang et al. Polymer-mediated immunocamouflage of red blood cells: effects of polymer size on antigenic and immunogenic recognition of allogeneic donor blood cells
US20030207247A1 (en) Preparation of red blood cells having reduced immunogenicity
Fisher et al. Properties of poly (ethylene glycol)-conjugated red blood cells
US11123441B2 (en) Methods and compositions for drug delivery
Emanuele FLOCOR™: a new anti-adhesive, rheologic agent
US6942859B2 (en) Red blood cells covalently bound with polymers
WO2004050848A2 (en) Methods for antigen masking of red blood cells resulting in reduced hemolysis
US8007784B1 (en) Antigenic modulation of cells
Scott et al. The other blood substitute: antigenically inert erythrocytes
Gill Resealed erythrocytes as a potential drug carrier system
Garratty Will stealth RBCs replace blood donors of rare types?
HASHEMI et al. Factorial design optimization of red blood cell PEGylation with a low molecular weight polymer
Sarvi et al. Surface treatment of red blood cells with monomethoxypoly (ethylene glycol) activated by succinimidyl carbonate
Sarvi et al. Surface coating of red blood cells with monomethoxy poly (ethylene glycol) activated with two different reagents
Cerda Cristerna Hemocompatibility and camouflaging efficiency of functionalized poly (dimethylamino-ethylmethacrylate) based polymers